AMGN logo

Amgen (AMGN)

Profile

Full Name

Amgen Inc.

Ticker Symbol

AMGN

Exchange

NASDAQ

Sector

Healthcare

Industry

Drug Manufacturers - General

Country

United States

IPO

June 17, 1983

Indexes

S&P 500,NASDAQ 100,Dow Jones

Website

http://www.amgen.com

Employees

28000

Key Details

Price

$274.48(-5.71%)

Market cap

$147.45B(Mega cap)

Last Dividend

$2.38

TTM Dividend yield

3.33%

Annual revenue

$33.42B(+18.57% YoY)

Annual EPS

$7.56(-39.47% YoY)

PE ratio

36.35

Next earnings date

May 1, 2025

Next ex-dividend date

May 16, 2025

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$274.48
AMGN price is $274.48

30-Day Relative Volume

1.20
AMGN 30-day relative volume is 1.20

Price Performance

Price Today change

-5.71%
AMGN price is down -5.71% today

Price YTD change

+5.31%
AMGN price is up +5.31% since January 1st

Price 1-year change

+3.01%
AMGN price is up +3.01% year-on-year

Price 3-year change

+8.91%
AMGN price is up +8.91% over the past 3 years

Price Range

Price All-time high

$346.85
AMGN price is currently -20.86% below its historical high of $346.85

Price 3-year low

$211.71
AMGN price is currently +29.65% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$147.45B
AMGN market capitalization is $147.45 billion

Market cap 3-year change

+9.52%
AMGN market capitalization is up +9.52% over the past 3 years

Market cap All-time high

$181.28B
AMGN market capitalization is currently -18.66% below its historical high of $181.28 billion

Market cap sector rank

99.1%
AMGN market capitalization is higher than 99.1% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+0.15%
AMGN shares outstanding is up +0.15% year-on-year

Shares Outstanding 3-Year Change

+0.56%
AMGN shares outstanding is up +0.56% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.42
AMGN beta is 0.42

200-day SMA

$306.48
AMGN price is currently -10.44% below its 200-day simple moving average

50-day SMA

$304.31
AMGN price is currently -9.80% below its 50-day simple moving average

RSI

40.02
AMGN 14-day relative strength index is 40.02

Volume

1.20
AMGN 30-day relative volume is 1.20

ATR

$11.80
AMGN average true range is $11.80

10-day Historical Volatility

40.12%
AMGN 10-day historical volatility is 40.12%

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Events

Last Paid Dividend

$2.38
AMGN last dividend was $2.38 per share, with an ex-dividend date of February 14, 2025

Next Dividend

$2.38
AMGN has announced a dividend of $2.38 per share, with an ex-dividend date set for May 16, 2025

Dividend per share

Dividend per share

$9.00
AMGN annual dividend per share is $9.00

Dividend per share Sector Rank

97.67%
AMGN annual dividend per share is higher than 97.67% of companies in Healthcare sector

Dividend per share 1-Year Change

+5.63%
AMGN annual dividend per share is up +5.63% year-on-year

Dividend per share 3-Year Change

+27.84%
AMGN annual dividend per share is up +27.84% over the past 3 years

Dividend yield

Dividend yield

3.28%
AMGN annual dividend yield is 3.28%

Dividend yield Sector Rank

62.35%
AMGN annual dividend yield is higher than 62.35% of companies in Healthcare sector

Other

Payout ratio

118.14%
AMGN annual payout ratio is 118.14%

Dividends paid

$4.83B
AMGN annual dividends paid is $4.83 billion

Free cash flow

$10.39B
AMGN annual free cash flow is $10.39 billion

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$33.42B
AMGN annual revenue is $33.42 billion

Revenue Analysts estimate

$35.11B
AMGN annual revenue is currently -4.81% lower than the consensus analysts' forecast

Revenue 1-year change

+18.57%
AMGN annual revenue is up +18.57% year-on-year

Revenue Sector rank

97.2%
AMGN annual revenue is higher than 97.2% of companies in Healthcare sector

EPS

EPS

$7.56
AMGN annual earnings per share is $7.56

EPS Analysts estimate

$20.65
AMGN annual earnings per share is currently -63.38% lower than the consensus analysts' forecast

EPS 1-year change

-39.47%
AMGN annual earnings per share is down -39.47% year-on-year

EPS Sector rank

97.27%
AMGN annual earnings per share is higher than 97.27% of companies in Healthcare sector

Profit

Gross profit

$20.57B
AMGN annual gross profit is $20.57 billion

Gross margin

61.53%
AMGN annual gross profit margin is 61.53%

Operating profit

$7.26B
AMGN annual operating income is $7.26 billion

Operating margin

21.71%
AMGN annual operating profit margin is 21.71%

Net income

$4.09B
AMGN annual net profit is $4.09 billion

Net margin

12.24%
AMGN annual net profit margin is 12.24%

Expenses

Total expenses

$26.17B
AMGN annual total expenses is $26.17 billion

Operating expenses

$13.31B
AMGN annual total operating expenses is $13.31 billion

Cost of goods sold

$12.86B
AMGN annual cost of goods sold is $12.86 billion

Selling, general & administrative expenses

$7.10B
AMGN annual SGA is $7.10 billion

Depreciation and amortization

$5.59B
AMGN annual depreciation & amortization is $5.59 billion

Interest expense

$3.15B
AMGN annual interest expense is $3.15 billion

Income tax

$519.00M
AMGN annual income tax is $519.00 million

EBIT & EBITDA

EBIT

$7.76B
AMGN annual earnings before interest & taxes is $7.76 billion

EBITDA

$7.76B
AMGN annual EBITDA is $7.76 billion

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$91.84B
AMGN annual total assets is $91.84 billion

Non current assets

$62.81B
AMGN annual long term assets is $62.81 billion

Current assets

$29.03B
AMGN annual total current assets is $29.03 billion

Cash and cash equivalents

$11.97B
AMGN annual cash & cash equivalents is $11.97 billion

Accounts receivable

$6.78B
AMGN annual accounts receivable is $6.78 billion

Inventory

$7.00B
AMGN annual inventory is $7.00 billion

Liabilities

Total liabilities

$85.96B
AMGN annual total liabilities is $85.96 billion

Long term liabilities

$62.86B
AMGN annual total long term liabilities is $62.86 billion

Current liabilities

$23.10B
AMGN annual total current liabilities is $23.10 billion

Accounts payable

$1.91B
AMGN annual accounts payable is $1.91 billion

Debt

Total debt

$60.10B
AMGN annual total debt is $60.10 billion

Total debt 1-year change

-6.99%
AMGN annual total debt is down -6.99% year-on-year

Long term debt

$56.55B
AMGN annual long term debt is $56.55 billion

Short term debt

$3.55B
AMGN annual short term debt is $3.55 billion

Equity & Capital

Shareholders equity

$5.88B
AMGN annual stockholders equity is $5.88 billion

Book value

$5.88B
AMGN annual book value is $5.88 billion

Retained earnings

-$27.59B
AMGN annual retained earnings is -$27.59 billion

Working capital

$5.93B
AMGN annual working capital is $5.93 billion

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

$11.49B
AMGN annual cash flow from operations is $11.49 billion

Cash from operations 1-year change

+35.64%
AMGN annual cash flow from operations is up +35.64% year-on-year

Cash from investing

-$1.05B
AMGN annual cash flow from investing activities is -$1.05 billion

Cash from investing 1-year change

+96.01%
AMGN annual cash flow from investing activities is up +96.01% year-on-year

Cash from financing

-$9.41B
AMGN annual cash flow from financing activities is -$9.41 billion

Cash from financing 1-year change

-144.73%
AMGN annual cash flow from financing activities is down -144.73% year-on-year

CAPEX

CAPEX

$1.10B
AMGN annual capital expenditures is $1.10 billion

CAPEX 1-year change

-1.44%
AMGN annual capital expenditures is down -1.44% year-on-year

Free Cash Flow

Free cash flow

$10.39B
AMGN annual free cash flow is $10.39 billion

Free cash flow 1-year change

+41.24%
AMGN annual free cash flow is up +41.24% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

61.53%
AMGN annual gross profit margin is 61.53%

Operating margin

21.71%
AMGN annual operating profit margin is 21.71%

Net margin

12.24%
AMGN annual net profit margin is 12.24%

ROA & ROE

ROA

4.33%
AMGN annual return on assets is 4.33%

ROE

67.55%
AMGN annual return on equity is 67.55%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

36.35
AMGN price to earnings ratio is 36.35

PE ratio Sector rank

70.59%
AMGN price to earnings ratio is higher than 70.59% of companies in Healthcare sector

PB Ratio

PB ratio

25.09
AMGN price to book ratio is 25.09

PB ratio Sector rank

97.53%
AMGN price to book ratio is higher than 97.53% of companies in Healthcare sector

PS Ratio

PS ratio

4.41
AMGN price to sales ratio is 4.41

PS ratio Sector rank

65.38%
AMGN price to sales ratio is higher than 65.38% of companies in Healthcare sector

Enterprise value

Enterprise value

$195.58B
AMGN enterprise value is $195.58 billion

Enterprise value Sector rank

99.34%
AMGN enterprise value is higher than 99.34% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

16.35
AMGN EV/EBITDA is 16.35

EV/EBITDA Sector rank

89.5%
AMGN EV/EBITDA is higher than 89.5% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

1.26
AMGN annual current ratio is 1.26

Quick ratio

0.95
AMGN annual quick ratio is 0.95

Leverage

Debt to equity

10.23
AMGN annual debt to equity ratio is 10.23

Interest coverage ratio

2.46
AMGN annual interest coverage ratio is 2.46

Risk & Stability

Piotroski F-Score

7
AMGN piotroski f-score is 7

Altman Z-Score

1.33
AMGN altman z-score is 1.33

Analyst ratings

Recent major analysts updates

Mar 5, 25 B of A Securities
Underperform
Feb 10, 25 Piper Sandler
Overweight
Feb 6, 25 B of A Securities
Underperform
Jan 28, 25 Citigroup
Neutral
Jan 24, 25 RBC Capital
Outperform
Jan 10, 25 Wells Fargo
Equal-Weight
Jan 8, 25 Truist Securities
Hold
Jan 2, 25 Piper Sandler
Overweight
Nov 27, 24 RBC Capital
Outperform
Nov 15, 24 Wolfe Research
Peer Perform

Institutional Ownership

Similar stocks

BSX logo
Boston Scientific (BSX)
TMO logo
Thermo Fisher Scientific (TMO)
SYK logo
Stryker (SYK)
DHR logo
Danaher (DHR)
GILD logo
Gilead Sciences (GILD)
SNY logo
Sanofi (SNY)
PFE logo
Pfizer (PFE)
ISRG logo
Intuitive Surgical (ISRG)
VRTX logo
Vertex Pharmaceuticals Incorporated (VRTX)
  • What is the ticker symbol for Amgen?
  • Does Amgen pay dividends?
  • What sector is Amgen in?
  • What industry is Amgen in?
  • What country is Amgen based in?
  • When did Amgen go public?
  • Is Amgen in the S&P 500?
  • Is Amgen in the NASDAQ 100?
  • Is Amgen in the Dow Jones?
  • When was Amgen's last earnings report?
  • When does Amgen report earnings?
  • Should I buy Amgen stock now?

What is the ticker symbol for Amgen?

The ticker symbol for Amgen is NASDAQ:AMGN

Does Amgen pay dividends?

Yes, Amgen pays dividends. The last payment was $2.38, with an ex-dividend date on February 14, 2025

What sector is Amgen in?

Amgen is in the Healthcare sector

What industry is Amgen in?

Amgen is in the Drug Manufacturers - General industry

What country is Amgen based in?

Amgen is headquartered in United States

When did Amgen go public?

Amgen's initial public offering (IPO) was on June 17, 1983

Is Amgen in the S&P 500?

Yes, Amgen is included in the S&P 500 index

Is Amgen in the NASDAQ 100?

Yes, Amgen is included in the NASDAQ 100 index

Is Amgen in the Dow Jones?

Yes, Amgen is included in the Dow Jones index

When was Amgen's last earnings report?

Amgen's most recent earnings report was on Feb 4, 2025

When does Amgen report earnings?

The next expected earnings date for Amgen is May 1, 2025

Should I buy Amgen stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page